Home / About Us / Law Enforcement Division /

Narcotics Enforcement Division

3375 Koapaka Street, Suite D-100
Honolulu, Hawaii 96819
Phone: 837-8470
Fax: 837-8474
E-mail: [email protected]

FORM REQUIRED FOR PRACTITIONER, APRN, AND PA RENEWALS:

2026 Prescriber Education Attestation Form

Hawaii Controlled Substance Registration
HI-PDMP -Hawaii-Prescription Drug Monitoring Program AwaRxE
Hawaii Controlled Substance Laws and Administrative Rules
In the News, Community Programs & Events
Controlled Substance Schedules

PRINT YOUR CERTIFICATE ONLINE

Effective January 1, 2024, you must retrieve and print your controlled substance certificate via your NED Self-Service Portal

GO TO: https://ned.ehawaii.gov/portal

HRS 329 (Title 19: Health HRS 329 Uniform Controlled Substances Act)
HRS 329 D (Title 19: Health HRS 329D Medical Marijuana Dispensary System)
HRS 712 (Title 37: Hawaii Penal Code HRS 712 Offenses Against Public Health and Morals) Note: Statutes pertaining to OFFENSES RELATED TO DRUGS AND INTOXICATING COMPOUNDS begin with HRS 712-1240
Title 23 Chapter 200 Administrative Rule: Regulation of Controlled Substances
Title 23 Chapter 201 Administrative Rule: Regulated Chemicals for the Manufacture of Controlled Substances

Federal Scheduling Actions 2018-2020

notice of Federal Scheduling Action brexanolone 2020
notice of emergency Scheduling Action etizolam and flualprazolam
notice of Federal Scheduling Action new controlled substances October 2021
notice of Federal Scheduling Action new fentanyls october 12 2020
notice of Federal Scheduling Action epidiolex August 21 2020
notice of Federal Scheduling Action norfentanyl April 17 2020
notice of Federal Scheduling Action solriamfetol january 7 2020
Act 256 2019/SB536 Prescription requirements related to schedule II drugs
federal scheduling action of fentanyl analogs August 2019
Act 190 became law 07-01-2018 (relating to scheduling actions of substituted cathinones,, cumyl-4-cn-binaca and dronabinol) Note: Archives contain previous emergency scheduling actions of these chemicals
Federal Scheduling Action Epidiolex October 2018

2018 and 2019 NEW & CHANGES TO THE LAW

Act 95 2019/SB 1263 Amends the Uniform Controlled Substance Act by updating Schedule V and amending requirements for electronic prescriptions, for consistency with federal law.
Act 230 2019/SB1486 Amends Electronic Prescription Accountability system (HI-PDMP)
Act 251 2019/HB665 Exceptions to query of Electronic Prescription Accountability System (HI-PDMP)
Act 256 2019/SB536 Prescription requirements related to schedule II drugs
Act 95 2019/SB 1263 Addition of FDA approved CBD drugs to Schedule V
Act 066/Senate Bill 505(2017) Effective 07-01-18. Requirement for policy or and written agreements to engage in an informed consent process between the prescribing provider and qualifying opioid therapy patient. Related Resource: Hawaii Department of Health, Patient Informed Consent Form also the Hawaii Revised Statute (HRS) 329.38-5
Act 151/House Bill 1602 Effective 08-01-18. Requires the inclusion of a label warning of the risks of addiction and death on the packaging of any opioid drug dispensed by a health care professional or pharmacist.
Act 153/Senate Bill 2646 Effective 07-01-18 Pertains to practitioner utilization requirements of the PDMP
Act 190/House Bill 2385 Effective 07-01-18. Relating to scheduling actions of substituted cathinones, cumyl-4-cn-binaca and dronabinol

K9 Kahu’s main duty is to assist with criminal investigations.
He locates hidden electronic storage devices such as cellular phones, thumb drives, and memory cards.

Facebook: Kahu Lum Lee & ESD K9 Kahu

k9_kahu